OneMedNet stockholders approve 1 million share plan increase and reverse split authority
At its September 18, 2026 virtual annual meeting, OneMedNet stockholders elected three Class III directors, ratified WithumSmith+Brown as auditor for 2026, and approved a 1,000,000-share increase to the 2022 Equity Incentive Plan. They also approved a charter amendment allowing a reverse stock split at a ratio between 1-for-5 and 1-for-20, to be set by the board.
Key points
- Stockholders approved adding 1,000,000 shares to the Amended and Restated 2022 Equity Incentive Plan, effective immediately.
- Proposal 4 approved a reverse split ratio from 1-for-5 to 1-for-20, with the final ratio left to the Board of Directors; 41,068,200 votes were cast for it.
- Dr. Kenneth Alleyne, Sherry Coonse McCraw and Dr. Jeffrey Yu were elected as Class III directors for terms expiring at the 2029 annual meeting.
- Votes represented 70.57% of eligible votes, which met the quorum requirement.
The filing
Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 23, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.